1. Home
2. -> Key Services
3. -> Clinical
4. -> Consultancy

Clinical Consultancy

Kinesis’ consultants offer state-of-the-art expertise in measurement, quantification and evaluation of a drug’s biological activity in humans. This extensive personal expertise will help sponsors to design the optimal early phase development program and clinical trials.
Kinesis has designed many early development plans and trials in a variety of disease area’s, such as virology, CNS, asthma/COPD, cardiovascular, urology, oncology, rheumatoid arthritis and psoriasis and thus has all the experience in house and can lean on and make use of an extensive clinical network of key experts.

Biomarkers

To achieve that goal, up-to-date knowledge of biomarkers, measurement techniques and indications is required. Therefore Kinesis’ (senior) consultants continuously update their knowledge, especially in those areas requiring their regular involvement. A close collaboration with an academic network of specialized clinics ensures utilization of best practices and the latest knowledge and techniques.

Clinical development program

Kinesis’ consultants can help sponsors with various activities in clinical development, ranging from designing a (synopsis for a) single clinical trial, or providing input to dose escalation steps during a trial, to providing full clinical development programs, pediatric investigation plans and participation as clinical representatives in project teams.

Outsourcing clinical development

Outsourcing the full clinical development program (or e.g. up to Proof of Concept) to Kinesis is also a possibility. In these cases a project team within Kinesis with representatives of all disciplines needed for clinical development (i.e. a consultant, trial manager, pharmacokineticist, pharmacokinetic/pharmacodynamic modeler (if applicable), statistician and medical writer), will take care of all clinical activities needed to bring the compound to its next milestone.